RCAPRCapricor Therapeutics Tokenized Stock (Reality)
Stock 24/7/365Issued by Reality
The company's R&D pipeline primarily targets the treatment of rare diseases, with a specific focus on advancing the clinical validation and commercialization of drugs for Duchenne muscular dystrophy (DMD).
- Macro context: RCAPR is part of the tokenized equities market, which represents only ~0.002% of global listed equity today.
Data as of Nov 1, 2026
Price performance
7D
+15.17%
14D
+2.44%
30D
—
1Y
—
All-time
-22.34%
Key facts
via /coins/{id}Market Cap Rank
#15004
Circulating Supply
416.78
Total Supply
416.78
All-Time High
$12.35 · 2026-09-30
Categories
News & Insights
Also tokenized by
Capricor Therapeutics Tokenized Stock (Reality) is issued as 2 separate tokens across different issuers.
| Issuer | Token | Price | Market Cap | 24h Volume | Networks |
|---|---|---|---|---|---|
| Ondo Finance | $7.24 | $2.09K | $100.77 |    |
CAPRONAlerts & digests
Coming soonReal-time price, NAV, mint, redemption alerts
Get pinged the moment RCAPR crosses a price or spread threshold you set, or automated.
Breaking news alerts
Issuer, regulatory and depeg news for RCAPR — the second it drops.
Daily summary
A once-a-day digest of RCAPR's price, best yield and market moves in your inbox.
Analyze & download 24/7 history
Full round-the-clock historical data for RCAPR — including off-market-hours — exportable to CSV.
Analyse with insight & news
AI-assisted analysis of RCAPR paired with the latest issuer, regulatory and market news.